Synthetic peptides representing a T-cell epitope as a carrier mo

Details Synthetic peptides representing a T-cell epitope as a carrier mo Synthetic peptides representing a T-cell epitope as a carrier mo

1995-06-07

1998-07-28

Achutamurthy, Ponnathapura

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

4241941, 4241931, 4241861, 4241851, 4241841, 424 17, 514 13, A61K 3912, A61K 3816, A61K 3808

Patent

active

057859736

ABSTRACT:
The present invention relates to novel T-cell epitopes of bacterial products. The epitopes of the invention may be employed in the preparation of conjugates between the epitopes and medically useful antigens, haptens, or antigenic determinants. These conjugates are capable of eliciting antibody responses similar to conjugates of antigens covalently coupled to carrier proteins, and in a vaccine composition, provide a safe and more economic conjugate vaccines.

REFERENCES:
patent: 4459286 (1984-07-01), Hilleman et al.
patent: 4496538 (1985-01-01), Gordon
patent: 4599230 (1986-07-01), Milich et al.
patent: 4599231 (1986-07-01), Milich et al.
patent: 4673574 (1987-06-01), Anderson
patent: 4695624 (1987-09-01), Marburg et al.
patent: 4711779 (1987-12-01), Porro et al.
patent: 4722840 (1988-02-01), Valenzuela et al.
patent: 4761283 (1988-08-01), Anderson
patent: 4762713 (1988-08-01), Anderson
patent: 4830962 (1989-05-01), Gelfand et al.
patent: 4886782 (1989-12-01), Good et al.
patent: 4902506 (1990-02-01), Anderson et al.
patent: 4925792 (1990-05-01), Rappuoli
patent: 4950740 (1990-08-01), Greenfield et al.
Francis, Michael J. et al., "Non-responsiveness to a Foot-and-Mouth Disease Virus Peptide Overcome by Addition of Foreign Helper T-cell Determinants", Nature, 300;168-170 (Nov. 12, 1987).
Goebel, W.F., "Studies on Antibacterial Immunity Induced by Artificial Antigens, " Hospital of the Rockefeller Institute for Medical Research, Dec. 1, 1938.
Maizels, R.M. et al., "Epitope Specificity of the T Cell proliferative Response to Lysozyme: Proliferative T Cells React Predominantly to Different Determinants From Those Recognized by B Cells, " Eur. J. Immunol., 10:509-515 (1980).
Schneerson, R., et al., "Preparation, Characterization, and Immunogenicity of Haemophilus Influenzae Type b Polysaccharide-Protein Conjugates, " J. of Experimental Medicine, 152:361-376 (1980).
Kyte, J. and Doolittle, R.F., "A Simple Method for Displaying the Hydropathic Character of a Protein, " J. Mol. Biol.,, 157:105-132 (1982).
Jolivet, M., et al., "Epitope Specific Immunity Elicited by a synthetic Streptococcal Antigen Without Carrier or Adjuvant, " Biochem. and Biophysical Research Comm., 117(2) :359-366 (1983).
Schutze, M-P., et al., "Carrier-Induced Epitopic Suppression, a Major Issue for Future Synthetic Vaccines," J. of Immun., 135 94) :2319-2322 (1985).
Atassi, M.Z., et al., "Non-Specific Peptide Size Effects in the Recognition by Site-Specific T-Cell Clones," Biochem. J., 246:307-312 91987).
Hopp, T.P. and Woods, K.R., "Prediction of Protein Antigenic Determinants from Amino Acid Sequences," Proc. Natl. Acad. Sci. USA, 78(6) :3824-3828 91981).
Watts, T.H., et al., "T-Cell Activation by Peptide Antigen: Effect of Peptide Sequence and Method of Antigen Presentation," Proc. Natl. Acad. Sci. USA, 82:5480-5484 (1985).
Good, M.F., et al., "Construction of Synthetic Immunogen: Use of New T-Helper Epitope on Malaria Circumsporozoite Protein," Science, 235:1059-1062 (1987).
Leclerc, C., et al., "A Synthetic Vaccine Constructed by Copolymerization of B and T Cell Determinants," Eur. J. Immunol., 17:269-273 (1987).
Bixler, G.S., Jr. and Atassi, M.Z., "Molecular Localization of the Full Profile of the Continuous Regions Recognized by Myoglobin Primed T-Cells Using Synthetic Overlapping Peptides Encompassing the Entire Molecule," Immunological Communications, 12(6) :593-603 (1983).
DeLisi, c. and Berzofsky, J.A., "T-Cell Antigenic Sites Tend to be Amphipathic Structures, " Proc. Natl. Acad. Sci. USA, 82:7048-7052 (1985).
Triebel, F., et al., "Immune Response to Diphtheria Toxin and to Different CNBr Fragments: Evidence for Different B and T Cell Reactivities," Eur. J. Immunol., 16:47-53 (1986).
Geyer, H., et al., "Immunochemical Properties of Oligosaccharide-Protein Conjugates with Klebsiella-K2 Specificity," Med. Microbiol. Immunol., 165:271-288 (1979).
Chu, C. et al., "Further Studies on Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates," Infection and Immunity, 40(1):245-256 (1983).
Schneerson, R., et al., "Serum Antibody Responses of Juvenile and Infant Rhesus Monkeys Injected with Haemophilus influenzae Type b and Pneumococcus Type 6A Capsular Polysaccharide-Protein Conjugates," Infection and Immunity, 45(3):582-591 (1984).
Geysen, H.M., et al., "The Delineation of Peptides Able to Mimic Assembled Epitopes," Ciba Foundation Symposium, 119:130-149 (1986).
Lise, L.D., et al., "Enhanced Epitopic Response to a Synthetic Human Malarial Peptide by Preimmunization with Tetanus Toxioid Carrier," Infection and Immunity, 55:2658-2661 (1987).
Milich, D.R., et al., "A Single 10-Residue Pre-S (1) Peptide Can Prime T Cell Help for Antibody Production to Multiple Epitopes Within the Pe-S(1), Pre-S(2), and S Regions of HBsAG," J. of Immunology, 138(12) :4457-4465 (1987).
Demotz, S., et al., "Delineation of Severasl Dr-Restricted Tetanus Toxin T Cell Epitopes," J. Of Immunology, 142(2) :394-402 (1989).
Fairweather, N.F., and Lyness, V.A., "The complete Nucleotide Sequence of Tetanus Toxin," Nucleic Acids Research., 14(19) :7809-7812 (1986).
Francis, M.J., et al., "Non-Responsiveness to a Foot-and-Mouth Disease Virus Peptide Overcome by Addition of Foreign Helper t-Cell Determinants," Nature, 300(12) :168-170 (1987).
Greenfield, L., et al., "Nucleotide Sequence of the Structural Gene for Diptheria Toxin Carried by Corynebateriophage .beta.," Proc. Natl. Acad. Sci. USA, 80:6853-6857 (1983).
Anderson, P., et al., "Immunization of 2-Month-Old Infants with Protein-Coupled Oligosaccharides Derived from the Capsule of Haemophilus Influenzae Type b," J. of Pediatrics, 107(3) : 346-351 (1985).
Margalit, H., et al., "Prediction of Immunodominant Helper T Cell Antigenic Sites From the Primary Sequence," J. Immunology, 138 (7) : 2213-2229 (1987).
Bixler, G.S., et al., "T Cell Recognition of Lysozyme: III. Recognition of the `Surface-Simulation`Synthetic Antigenic Sites," J. of Immunogenetics, 11:245-250 (1984).
Jolivet, M.E., et al., "Induction of Biologically Active Antibodies by a Polyvalent Synthetic Vaccine Constructed Without Carrier," Infection and Immunity, 55(6) :1498-1502 (1987).
Bixler, G.S., et al., "T Cell Recognition of Myoglobin. Localization of the Sites Stimulating T Cell Proliferative Responses by Synthetic Overlapping Peptides Encompassing the Entire Molecule," J. of Immunogenetics, 11:339-353 (1984).
Bixler et al, Adv. Exp. Med. Biol., 251, pp.175-80 (1989), Chem. Abs. 113(11), 95766t.
Bigio et al, FEBS Lett., vol. 218(2), pp. 271-6, (1987), Chem. Abs. vol. 107(17), 1495732.
Audibert et al., Proc. Natl. Acad. Sci., vol. 79(16), pp. 5042-6, (1982), Chem. Abs., vol. 97(21), 179864n.
Hu et al, Biochem. Biophys. Acta, vol. 902(1), pp.24-30(1987), Chem. Abs. vol. 107(13), 1107892.
Comanducci et al, Nucleic Acid Res., vol. 15(14), pp. 5897, (1987), Chem. Abs., vol. 107(13), 110183x.

Affiliated with

Also associated with

Rating

Synthetic peptides representing a T-cell epitope as a carrier mo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthetic peptides representing a T-cell epitope as a carrier mo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic peptides representing a T-cell epitope as a carrier mo will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-21017